Dr. Reddy'S Laboratories recalls Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepal
Recalled April 10, 2013 · FDA recall D-238-2013 · Dr. Reddy'S Laboratories
Hazard
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details. · FDA Class III
Units
117,546 bottles
Sold at
Nationwide and Puerto Rico.
Description
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
Product
Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.
Manufacturer(s)
Dr. Reddy'S Laboratories
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →